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Abstract: 
My senior research project was completed at S1. Jude Children's Research 
Hospital in Memphis, TN. I did my work in the Genetics department in the lab of Dr. 
Guillermo Oliver during the summers of2001 and 2002. Dr. Oliver's lab uses mice as a 
model to study developmental genetics and embryology. I had a different project each 
summer, and both of these projects are related in many aspects. The overall goal of both 
of my projects was to try to understand the function of genes that are expressed in the 
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developing mouse embryo. The first summer I focused mostly on the gene Six 2, and the 
second summer I focused on gaining a better understanding three genes expressed in the 
developing lymphatic system. The first summer I learned a tremendous amount about 
cloning techniques, and I make a the knockout construct for the gene Six 2. The second 
summer I made the conditional knockout construct for the gene Prox 1, since the 
complete knockout is lethal before birth. I undertook another project the second summer, 
which was very educationa~ but unfortunately unsuccessful. In this project, I attempted 
to do a yeast two-hybrid screening of a mouse E 1 0.5 cDNA library to look for genes 
whose protein products physically interacted with the products of VEGF-C and Flt-4. 
Although many of the results of these experiments are not complete, I think they will be 
very interesting. 
The Six family of hom eo box genes acts as transcription factors activating other 
genes, and initiating some developmental processes (1). The Six family of genes are 
evolutionarily conserved and can be found in organisms ranging from Drosophila to 
humans (1). The Six family was identified with the discovery of its fIrst member, 
Drosphila sine oculus, a gene very important in compound eye formation (1). 
Most members of the Six family contain a very similar domain called the "Six 
Domain," which contains 110-115 amino acids. Since these genes are also homeobox 
genes, they also contain a conserved homeodomain which is around sixty amino acids in 
length. This family's homeodomain is quite unique when compared to that of other 
homeobox genes. The domain does not include an arginine at position five or a 
glutamine at position twelve in the first helix. These residues are usually responsible for 
the binding of the transcription factor to the T AAT binding sequence. So, as would be 
expected, the Six family of genes does not bind to DNA containing the T AA T sequence. 
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Six 2 is one of the members of this family, and this is the gene on which part of 
my project was focused. Six 2 is located on mouse chromosome 17, and its expression is 
not seen before day E8.5 in development (2). So far only a single transcript of Six 2 has 
been found, which is approximately 2.3 K.B (2). Six 2 is expressed largely in the 
developing connective tissues of the body such as tendons (2). However Six 2 is also 
expressed in the sensory placodes of early embryos around E9.5, which will later give 
rise to the eyes and the ear (1). Other areas of Six 2 expression include the head 
mesenchyme E8.5, brachial arches E9.5, primitive kidneys EI0.5, and genitals Ell.5 (2). 
To try and better understand the function of the gene, I began a loss of function 
experiment or a knockout. When I arrived, Dr. Oleg Lagutin had already cloned the 
genomic fragment of Six 2 into a plasmid he named CESI. He had also designed the 
construct, and the majority of my project was creating this knockout construct. 
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First, I started with the plasmid CES1 (Six 2) which was digested with EcoRl to 
obtain the 2.S K.B. and 1.6 K.B. Six 2 I EcoRl fragments. These fragments were isolated 
using gel electrophoresis and gel extraction of the DNA. The 2.S K.B. fragment was 
used as the 3' arm of the knockout construct. The 1.6 K.B. fragment was used to detect 
the proper recombination of the construct with the genomic DNA. Both of these 
fragments were cloned separately into the vector pbluescript II KS. In preparation for 
this cloning, pbluescript II KS was digested with EcoRl to linearize the vector. Next, the 
S' phosphates were removed to prevent self-ligation of the vector. The two EcoRl 
fragments were ligated (sticky/nondirectional) into separate vectors resulting in plasmid 
CI, which contains the 2.S K.B. Fragment, and CJ, which contains the 1.6 K.B. fragment. 
The purpose of creating CI was to conveniently modify the 3' arm by removing a 
Hind III site, without altering the final construct. The removal of the Hind III site within 
the 3' arm was used as part of the strategy to detect correct construct genomic 
recombination. To remove this site, CI was partially digested with Hind III. Gel 
electrophoresis and extraction of the DNA was preformed to isolate the fragments only 
cut once in the desired place. The ends were then blunted with Klenow, and the plasmid 
was self-ligated. This self-ligation will result in the elimination of the Hind III site in the 
3' arm of the construct, and they new plasmid was called CK. 
The vector for the final construct, pKO Scrambler NTKV -1901, contains two 
scrambler sites for the introduction of the S' and 3' arms of the construct. It also contains 
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a neomycin resistance gene as positive selection and thymidine kinase as negative 
selection. This vector was digested with EcoRl and dephosphorylated at the scrambler B 
site. CK was digested with EcoRl to remove the 2.5 K.B. 3' arm of the construct. Both 
the vector and insert were ran out on an agarose gel and purified by gel extraction to be 
ligated together (sticky/nondirectional). The resulting plasmid is called CL. 
CESI was used again to obtain the 5' arm of the construct. CESI was digested 
with Nco 1 , which will linearize the plasmid, and Klenow was used to blunt the ends of 
the fragment. It was then digested with Hind III. The 5' arm of the construct can be 
isolated as a 6.2 K.B. fragment upon gel electrophoresis and extraction of the DNA. CL, 
which is pKO scratnbler NTKV -1901 already containing the 3' arm, was first digested 
with Xho 1, and the ends were blunted with Klenow. It was then digested with Hind III. 
The ends of the insert and vector were blunted due to the incompatibility of the Nco 1 and 
Xho 1 ends. A ligation was set and the resulting plasmid was the fmal construct and 
named CM (blunt/sticky/directional). This construct was sequenced and all junctions 
were correct, so I concluded that CM was the desired fmal Six 2 knockout construct. 
Appendix page 1 shows CM map, and page 2 details how the construct will recombine 
with the genomic DNA. 
The proper recombination of the construct with the genomic DNA will be 
detected using CJ, which contains the 1.6 K.B. EcoRl fragment that will be used as a 
probe in a Southern blot. After electroporation of the embryonic stem cells, the genomic 
DNA will be digested with Hind III, and the radioactive probe will be used to identify the 
fragment that includes the 1.6 K.B. probe area. If recombination has occurred in the 
proper place, then one of the Hind III sites will be absent and the probe will adhere to a 
larger fragment. If the construct has not recombined in the proper place, then the probe 
will adhere to a 3.0 K.B. fragment. 
Another member of the lab, Michelle Self, took over the Six 2 knockout project 
while I returned to school. She did the electroporation of the embryonic stem cells and 
selected cells that had undergone the proper recombination with the knockout construct. 
The original plan was for me to return to St. Jude the next summer and analyze the Six 2 
mutants, but unfortunately the knockout mice were not rom in time for me to analyze 
them. 
Results & Discussion: 
On October 2,2002 I received notification that the first Six 2 knockout litter had 
been rom and the mice died at birth. The mice appeared to be normal from the exterior 
of the rody, but upon dissection, it was discovered that the mice had no kidneys. 
Preliminary analysis has shown that the mesonephros and metanephros are present E9.5 
through E 14.5. The metanephros, which would persist to function as the kidney 
degenerates sometime between E 14.5 and birth. 
Another phenotype of the knockout has recently been discovered. Although this 
is preliminary data, it seems as if all the cells in the retina look morphologically 
abnormal. It has been hypothesized that there is a defect in amacrine cell differentiation. 
Experiments are currently being performed to better understand this. 
There are still a tremendous number of experiments to be done. It would be very 
interesting to see how the connective tissues of the knockout mice are affected, since Six 
2 is highly expressed in this tissue (2). I am also anxiously awaiting the results of 
experiments which detail how the expression of other genes are affected by the absence 
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of Six 2. These experiments would help to elucidate developmental pathways. Since this 
gene is a transcription factor, it is expected to affect to have some very interesting results. 
I also think it would be beneficial to make a conditional knockout, since the mutation is 
lethal. This is the same type of experiment that I did in another part of my project, and it 
will allow us to see the tissue specific effects of the gene while avoiding lethality. 
Although my aspect of the project is fInished, I plan to keep in touch with the lab and 
stay updated on any new results that are obtained. 
Proxl 
The next gene studied was Proxl, a vertebrate homeobox gene related to the 
Drosophila gene prospero (3). Proxl is expressed in the eNS, liver, heart, lens, retina, 
pancreas, skeletal muscle, and lymphatic endothelial cells of mice (3). The polarized 
expression of this gene by a subset of cells the cardinal vein gives these cells a bias 
towards becoming lymphatic tissue (4). Upon the expression of other genes, one of 
which will be discussed later, these cells bud off and become the first lymphatic 
endothelial cells (4). A knockout of Proxl was developed, and the mice died before birth 
(3). Analysis of the knockout embryos showed that cells did begin to bud from the 
cardinal vein, but did not continue to develop into lymphatic vessels (3). It was 
concluded that Proxl expression is required to maintain budding and develop lymphatics 
(3). 
Analysis of Proxl heterozygotes has been done, and it has yielded some 
interesting results, all of which indicate a disruption in lymphatic development (3). The 
mice have lymph edema, a build up of chyle in the intestines, and abnonnalities in the 
positions of lymphatic vessels (see appendix page 3) (3). It is desirable to make a 
conditional knockout of Proxl to see how inactivating the gene at particular times and 
places in development will affect the tissue while avoiding lethality. 
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Dr. Natasha Harvey had already designed the construct and cloned part of the 
genomic sequence of Prox 1 in plasmids P23 and P5. My job was to execute the plans 
and create the knock-out construct. The frrst step was to cut the 3' arm of the construct 
out of the P23 plasmid. This arm contains exons 2 and 3 of the Prox 1 gene. P23 was 
digested with Cia I (sticky) and EcoRV (blunt) to generate the 8.8 KB insert fragment. 
Then next step was to digest the vector, pNeotkLoxP, with Sal I and then blunt the end 
with Klenow. The vector was digested with CIa 1. The fIrst ligation was set with the 3' 
arm and pNeotkLoxP (directionallstickylblunt). To prepare for the ligation of the 5' arm 
into the construct P5 was digested with Not I and blunted with Klenow. This generates 
the 2.2 KB insert fragment. To prepare the vector for this ligation, pNeotkLoxP + 3' arm 
was digested with EcoRV (blunt) and Hind III, which was blunted with Klenow. The 
second ligation is a blunt, nondirectionalligation. 
The next steps for the conditional knockout will be to electroporate the embryonic 
stem cells and select cells which have under gone the proper recombination. Dr. Harvey 
introduced LoxP sites into the intron sequence of Prox 1 as can be seen in figure 1 on the 
next page. When the construct recombines with the genomic DNA it will appear as in the 
frrst line of the figure. When a mouse who is homozygous for the Prox 1 conditional 
knockout is crossed with a line of CreLoxP mice, their offspring will be the ones to 
express the desired phenotype. Depending on the line of Cre mice the used, Cre 
recombinase will be expressed in a certain tissue, at a certain time and cleavage of the 
8 
construct will occur. The ultimate result will be the bottom line, in which Prox 1 is not 




-- . ------------------------• c---
LoxP 
Figure 1. This describes the way this construct will work in a developing embryo expressing CreRecombinase. The 
end result will be the cleavage and removal of exons 2 and 3. This will leave Prox 1 nonfunctional. 
Results & Discussion: 
After three ligation attempts, one arm of the Proxl conditional knockout was 
successfully ligated in the proper orientation. When I left St. Jude, colonies were still 
being screened to see if any of the ligations for the second arm were successful. I was 
notified in September that a colony hybridization revealed that the construct was 
complete. Sequencing has been ordered to check the junctions in the construct. Dr. 
Natasha Harvey has taken over the project, and I expect to have the first Prox 1 
conditional knockout mouse around December 2003. 
VEGF ... C and Flt-4 Yeast-two hybrid library screening 
The other genes being studied in the yeast-two hybrid library screening are Flt-4 
and VEGF-C. Flt-4 (also known as VEGFR-3) is first expressed in developing blood 
vessels and later in lymphatics (4). Flt-4 is a vascular endothelial growth factor receptor. 
It is one of the fITst genes expressed by cells that bud off from the cardinal vein to 
develop into lymphatics (4). Later in adulthood, Flt-4 is expression is restricted to 
lymphatic tissue (4). A missense mutation in Flt-4 results in a genetic disorder called 
Milroy disease (4). This disease results in lymph edema and is due to a missense 
mutation that disrupts the tyrosine kinase activity of Flt-4 (see figure 2 below) (4). 
VEGF-C is a vascular endothelial growth factor, and it is the ligand of Flt-4 (4). Over 
expression of this gene induces lymphangiogenesis, which could be important in tumor 
growth and metastasis (4). It would be interesting to see what other proteins or co-
factors these molecules bind, since they are both present in lymphatic vessels. This will 
be accomplished by a yeast-two-hybrid library screening. 
, R l 
Fig. 4. 9 year-old girl with chylous reflux and left leg 
lymphedema. Injection of radiotracer only into the Tight 
foot refluxes into the left aU the to the foot. 
Figure 2. A 9 year old child with Milroy Disease. Note the lymph 
edema that results from a mutation in Flt-4. 
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Flt-4 and VEGF-C DNA was obtained for the library screening constructs by RT-
PCR from eDNA. The PCR primers were designed to incorporate an additional Not I and 
Sal I site on the ends of the fragment to facilitate future cloning. The PCR products were 
ligated into pgem-T -easy because the PCRs were very sensitive, and only small amounts 
of DNA could be made. The next step was to clone the genes into the vector that would 
be used for the library screening, PC97B. 
The library screening will help to identify any genes in the mouse EI0.5 eDNA 
library that physically interact with the bait gene (VEGF-C or Flt-4). This is done by 
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cloning genes in frame with domains of a transcription factor. The only way that the 
transcription factor can activate its target gene is if the bait protein and the library protein 
bind to one another. The concept is that if the bait and library proteins interact the two 
domains of the transcription factor will be in the correct locations to activate the reporter 
genes. A figure on appendix page 4 illustrates this concept. The reporter genes were 
lac Z, HIS 3, and URA 3. The lac Z provided the opportunity to use IPTG and X-GAL to 
test for positive (blue) colonies. The HIS 3 and URA 3 genes allowed for selection of 
positive colonies as ones that can survive on plates lacking histidine and uracil. 
Results & Discussion 
Seven ligation attempts were made to ligate Flt-4 into PC97B, and none were 
successful. VEGF-C was cloned parallel to Flt-4, and the second ligation attempt was 
successful for VEGF-C. During this time both genes were sequenced in pgem-T-easy, 
and both were found to have missence and nonsense mutations as a result of PCR. 
Unfortunately due to the sensitivity of the reactions, none of the high fidelity polymerases 
worked. The PCRs were very hard to optimize, and successful reactions were not 
reproducible. The mutation in Flt-4 produced a stop codon in the middle of the sequence, 
so this clearly means that we must go back and obtain Flt-4 sequence that is not mutated 
either by PCR or other means. At the end of my time at St. Jude, no clonings of Flt-4 had 
been done without mutations. In order for the library screening to be successful, a fully 
functional protein had to be produced, so this project has not made any significant 
progress. There were two mutations in VEGF-C. One involved changing a tyrosine to 
methionine and the other changed a proline to leucine. These mutations are clearly not 
extreme changes, and they are not in functional or conserved domains. However, since 
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wild-type protein conformation is essential in this experiment the results obtained using 
the mutated constructs would have to be repeated to confirm that there is an interaction 
between the wild-type VEGF-C and the library protein. When the sequencing errors 
were discovered, the VEGF-C library screening was already underway. Nineteen clones 
had passed the His selection and other screenings were underway. New VEGF-C PCR 
cloning attempts were also started. Currently another member of the lab, Jaime Morgan, 
is attempting to clone both of these genes, and she has had no success. 
Conclusion: 
The fmal result of my senior research project, as of Nov. 14,2002 is to have 
developed the knock out construct for Six 2 and the conditional knock out construct for 
Prox 1. Overall, I feel that my project was a success most importantly because I learned 
so much information in those two summers. I also feel that in doing my project I utilized 
and combined the information from almost all of my classes, and it was truly an 
educational conclusion to my undergraduate education. 
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